CEA

Product Description

The Biorex Diagnostics Carcinoembryonic Antigen (CEA) ELISA kit is a quantitative microplate enzyme immunoassay (ELISA) developed for the precise and reliable measurement of carcinoembryonic antigen in human serum or plasma. Carcinoembryonic antigen is a well-established tumour-associated glycoprotein commonly used as a biomarker in oncology, particularly in colorectal cancer, as well as other gastrointestinal, pancreatic, lung, and breast malignancies. Accurate laboratory measurement plays a critical role in supporting clinical evaluation, treatment planning, and long-term patient monitoring.

Quantitative assessment of CEA is widely utilised for monitoring disease progression and therapeutic response rather than for primary cancer screening. Rising concentrations may indicate tumour recurrence or metastasis, while decreasing levels often reflect effective treatment response. Regular monitoring therefore provides clinicians with valuable insight into treatment efficacy, disease stability, and the need for further diagnostic investigation. In addition to clinical diagnostics, measurement of this tumour marker supports oncology research and clinical trials focused on cancer progression and therapeutic outcomes.

Key Features

• Quantitative Microplate ELISA – Enables accurate and reproducible determination of antigen concentrations across a clinically relevant range.
• High Sensitivity and Specificity – Ensures reliable detection with minimal cross-reactivity or analytical interference.
• Colourimetric ELISA Format – Standardised assay design with dependable optical readouts compatible with routine laboratory equipment.
• Serum and Plasma Compatibility – Validated for use with commonly collected human sample types.
• Ready-to-Use Components – Includes pre-formulated reagents, standards, and controls to streamline laboratory workflows and reduce preparation time.
• Quality-Controlled Performance – Manufactured under strict quality standards to ensure consistency, accuracy, and reproducibility across assay runs and laboratories.

The Biorex Diagnostics CEA ELISA kit is suitable for use in hospital laboratories, diagnostic centres, and research institutions requiring dependable quantitative results. Its microplate format supports efficient batch testing and high-throughput workflows, making it well suited for routine oncology monitoring and long-term patient follow-up. By delivering precise and reproducible measurements, the assay supports informed clinical decision-making, improved patient management, and ongoing research into cancer diagnosis and treatment outcomes.

Contact Us for more information.